References

Dementia

10.1136/bmj.b75 · 2009 · External reference

10.1038/nrneurol.2012.263

10.1038/nrneurol.2012.263 · External reference

Donepezil for dementia due to Alzheimer's disease

2006 · External reference

Biessels2006 - Dementia and diabetes review

10.1016/s1474-4422(05)70284-2 · 2006 · External reference

BarrettConnor2007 - obesity and dementia review

2007 · External reference

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study

10.1136/bmj.38446.466238.e0 · 2005 · External reference

Inflammation and Alzheimer's disease

10.1016/s0197-4580(00)00124-x · 2000 · External reference

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

10.1212/wnl.47.2.425 · 1996 · External reference

Risk of Alzheimer's disease and duration of NSAID use

10.1212/wnl.48.3.626 · 1997 · External reference

Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population

10.1159/000075957 · 2004 · External reference

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

10.1136/bmj.327.7407.128 · 2003 · External reference

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging

10.1093/aje/kwf074 · 2002 · External reference

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

10.1159/000078501 · 2004 · External reference

Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease

10.1056/nejmoa010178 · 2001 · External reference

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County study

10.1212/wnl.59.6.880 · 2002 · External reference

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

10.1212/01.wnl.0000260269.93245.d2 · 2007 · External reference

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

10.1001/jama.289.21.2819 · 2003 · External reference

Rofecoxib protocol 078 study group, a randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

10.1038/sj.npp.1300690 · 2005 · External reference

Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease?

10.1056/nejm200111223452110 · 2001 · External reference

10.1523/jneurosci.20-15-05709.2000

10.1523/jneurosci.20-15-05709.2000 · External reference

Indomethacin reverses the microglial response to amyloid beta-protein

10.1016/s0197-4580(98)00047-5 · 1998 · External reference

10.1161/01.cir.101.10.1206

10.1161/01.cir.101.10.1206 · External reference

ABC of antithrombotic therapy: an overview of antithrombotic therapy

10.1136/bmj.325.7367.762 · 2002 · External reference

Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis

10.3233/jad-141506 · 2015 · External reference

10.1523/jneurosci.23-20-07504.2003

10.1523/jneurosci.23-20-07504.2003 · External reference

Introduction: mechanism of action of NSAIDs

10.1093/rheumatology/35.suppl_1.1 · 1996 · External reference

NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo

10.1172/jci18162 · 2003 · External reference

10.1038/35102591

10.1038/35102591 · External reference

No advantage of a beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies

10.1212/01.wnl.0000313933.17796.f6 · 2008 · External reference

NSAID use and dementia risk in the cardiovascular health study: role of APOE and NSAID type

10.1212/01.wnl.0000284596.95156.48 · 2008 · External reference

A blood Gene expression marker of early Alzheimer's disease

10.3233/jad-2012-121363 · 2013 · External reference

AddNeuroMed-the European collaboration for the discovery of novel biomarkers for Alzheimer's disease

10.1111/j.1749-6632.2009.05064.x · 2009 · External reference

Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's disease

10.1038/srep12393 · 2015 · External reference

Gene expression changes in the course of normal brain aging are sexually dimorphic

10.1073/pnas.0806883105 · 2008 · External reference

10.1038/nrc2044

10.1038/nrc2044 · External reference

10.1126/science.1132939

10.1126/science.1132939 · External reference

10.1038/nrn3880

10.1038/nrn3880 · External reference

A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease

10.1007/bf03325217 · 2009 · External reference

Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's disease anti-inflammatory prevention trial: variable effects of NSAIDs in ADAPT

2011 · External reference

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case–control study

10.1016/s0140-6736(05)17864-7 · 2005 · External reference

Extended results of the Alzheimer's disease anti-inflammatory prevention trial

10.1016/j.jalz.2010.12.014 · 2011 · External reference

10.1097/jgp.0b013e31818cd3a4

10.1097/jgp.0b013e31818cd3a4 · External reference

10.1126/science.1151526

10.1126/science.1151526 · External reference

10.1126/science.1158799

10.1126/science.1158799 · External reference

10.1016/j.wneu.2010.12.055

10.1016/j.wneu.2010.12.055 · External reference

Brain metabolic dysfunction at the core of Alzheimer's disease

10.1016/j.bcp.2013.12.012 · 2014 · External reference

10.1111/j.1749-6632.1999.tb07824.x

10.1111/j.1749-6632.1999.tb07824.x · External reference

10.1016/s0024-3205(99)00442-7

10.1016/s0024-3205(99)00442-7 · External reference

10.1111/j.1600-0404.1996.tb05868.x

10.1111/j.1600-0404.1996.tb05868.x · External reference

Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress

10.1155/2015/985845 · 2015 · External reference

Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer's disease

10.1155/2015/105828 · 2015 · External reference

10.1523/jneurosci.3040-05.2005

10.1523/jneurosci.3040-05.2005 · External reference

10.1016/s0047-6374(98)00095-5

10.1016/s0047-6374(98)00095-5 · External reference

10.1074/jbc.m500526200

10.1074/jbc.m500526200 · External reference

10.1242/dmm.020529

10.1242/dmm.020529 · External reference

10.1038/nrc3496

10.1038/nrc3496 · External reference